Correlation Between G Medical and Bionano Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both G Medical and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G Medical and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G Medical Innovations and Bionano Genomics, you can compare the effects of market volatilities on G Medical and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G Medical with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of G Medical and Bionano Genomics.

Diversification Opportunities for G Medical and Bionano Genomics

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between GMVD and Bionano is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding G Medical Innovations and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and G Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G Medical Innovations are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of G Medical i.e., G Medical and Bionano Genomics go up and down completely randomly.

Pair Corralation between G Medical and Bionano Genomics

Given the investment horizon of 90 days G Medical Innovations is expected to under-perform the Bionano Genomics. In addition to that, G Medical is 1.53 times more volatile than Bionano Genomics. It trades about -0.18 of its total potential returns per unit of risk. Bionano Genomics is currently generating about -0.15 per unit of volatility. If you would invest  94,200  in Bionano Genomics on November 2, 2024 and sell it today you would lose (93,681) from holding Bionano Genomics or give up 99.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy22.67%
ValuesDaily Returns

G Medical Innovations  vs.  Bionano Genomics

 Performance 
       Timeline  
G Medical Innovations 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days G Medical Innovations has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, G Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

G Medical and Bionano Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with G Medical and Bionano Genomics

The main advantage of trading using opposite G Medical and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G Medical position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.
The idea behind G Medical Innovations and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine